Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,686 | 2,751 | 2,824 | 2,916 | 4,346 |
| Receivables | N/A | 9 | 20 | 11 | 27 |
| TOTAL | $2,704 | $2,787 | $2,855 | $2,957 | $4,416 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 1 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $3 | $3 | $3 | $3 | $3 |
| Total Assets | $2,707 | $2,790 | $2,858 | $2,961 | $4,420 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50 | 48 | 48 | 62 | 53 |
| Accrued Expenses | 10 | 18 | 1 | 9 | 30 |
| TOTAL | $60 | $65 | $49 | $70 | $83 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $60 | $65 | $49 | $70 | $83 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 102 | 102 | 102 | N/A |
| Common Shares | 33 | 33 | 33 | 33 | 33 |
| Retained earnings | 2,157 | 2,235 | 2,319 | 2,400 | 2,503 |
| Other shareholders' equity | -344 | -344 | -344 | -344 | 0 |
| TOTAL | $2,647 | $2,725 | $2,809 | $2,890 | $4,337 |
| Total Liabilities And Equity | $2,707 | $2,790 | $2,858 | $2,961 | $4,420 |